Mipomersen Pregnancy and Breastfeeding Warnings

Mipomersen is also known as: Kynamro

Mipomersen Pregnancy Warnings

FDA pregnancy category: B Mipomersen should be used in pregnancy only if clearly needed. Females of reproductive potential should be encouraged to use effective contraception during mipomersen therapy.

There are no controlled data in pregnant women. Reproduction and embryofetal development studies performed in mice at doses up to 87.5 mg/kg/week given by subcutaneous administration from mating through organogenesis and in pregnant rabbits given 52.5 mg/kg/week, show no evidence of impaired fertility or harm to the fetus at 2 (mice) to 5 (rabbits) times clinical exposure at a 200 mg/week therapeutic dose.

Mipomersen Breastfeeding Warnings

A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Yes The effects in the nursing infant are unknown.

Lactating rats administered mipomersen at doses up to 70 mg/kg/week (3 times the anticipated systemic exposure from a 200 mg/week dose consumed less food while nursing. This correlated with reduced weight gain in the rat pups, and decreased pup survival.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)